Skip to content

Status of Surgical Resection and Histologic Subtype as Predictors of Local Recurrence in Retroperitoneal Liposarcoma

Status of Surgical Resection and Histologic Subtype as Predictors of Local Recurrence in Retroperitoneal Liposarcoma - Case Series

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05428579
Enrollment
60
Registered
2022-06-23
Start date
2017-10-01
Completion date
2018-11-01
Last updated
2022-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liposarcoma of Soft Tissue, Surgical Procedure, Unspecified

Keywords

retroperitoneal liposarcoma, overall survival, local recurrence free survival

Brief summary

Soft tissue sarcomas are rare malignant tumors. Liposarcoma constitute the most frequent histological subtype of retroperitoneal sarcoma. The prognosis of soft tissue sarcomas depend on clinical and histologic characteristics. Objective: Evaluate variables that may be related to overall survival and local recurrence free survival in patients with retroperitoneal liposarcoma. Methods: retrospective analysis of medical records of 60 patients attended from 1997 to 2017, who underwent surgical resection of retroperitoneal liposarcoma.

Interventions

PROCEDURERetroperitoneal Liposarcoma resection

Retroperitoneal Liposarcoma resection

Sponsors

University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
17 Years to 76 Years
Healthy volunteers
No

Inclusion criteria

* All patients who underwent surgical resection of retroperitoneal liposarcoma

Exclusion criteria

* Unresectable disease (upper mesenteric artery or vein involvement) or metastatic disease (sarcomatosis or distant disease)

Design outcomes

Primary

MeasureTime frame
Overall survival rate60 months
Local recurrence-free survival rate60 months

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026